Yahoo
NasdaqGM - Nasdaq Real Time Price USD

IRADIMED CORPORATION (IRMD)

76.68 -9.06 (-10.57%)
At close: October 30 at 4:00:00 PM EDT
Trade IRMD on Coinbase
Chart Range Bar
Loading chart for IRMD
Chart does not reflect overnight price.
  • Previous Close 85.74
  • Open 82.28
  • Bid 66.38 x 200
  • Ask 118.27 x 200
  • Day's Range 76.35 - 82.28
  • 52 Week Range 76.35 - 107.90
  • Volume 218,005
  • Avg. Volume 122,467
  • Market Cap (intraday) 980.596M
  • Beta (5Y Monthly) 0.91
  • PE Ratio (TTM) 41.01
  • EPS (TTM) 1.87
  • Earnings Date Oct 30, 2026
  • Forward Dividend & Yield 0.80 (1.04%)
  • 1y Target Est 118.00
  • Motley Fool Rating Bullish

IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible intravenous infusion pump systems and MRI compatible patient vital signs monitoring systems and related accessories. The company offers MRidium 3870 and 3860+ MRI Compatible IV Infusion Pump System with associated disposable IV tubing sets; 3880 MRI compatible patient vital signs monitoring system; and 3600 FMD1 with remote alarm logging unit ferromagnetic detection device. It also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. The company serves hospitals, acute care facilities, and outpatient imaging centers. It sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors in the United States and internationally. The company was incorporated in 1992 and is headquartered in Orlando, Florida.

www.iradimed.com

166

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Medical Devices

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

IRMD
20.66%
S&P 500 (^GSPC)
10.73%

1-Year Return

IRMD
1.73%
S&P 500 (^GSPC)
11.11%

3-Year Return

IRMD
100.21%
S&P 500 (^GSPC)
81.91%

5-Year Return

IRMD
126.25%
S&P 500 (^GSPC)
64.59%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY26
Revenue 24.2M
Earnings 6.51M
Profit Margin 26.88%

Q4

FY25

Q1

FY26

Q2

FY26

Q3

FY26

0
5M
10M
15M
20M
26.0%
27.0%
28.0%

Analyst Insights

View More

Analyst Price Targets

116.00
118.00 Average
76.68 Current
120.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Latest Rating

Date 9/22/2026
Analyst Needham
Rating Action Initiated
Rating Hold
Price Action --
Price Target --

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    26.85%

  • Return on Assets (ttm)

    15.30%

  • Return on Equity (ttm)

    23.42%

  • Revenue (ttm)

    89.34M

  • Net Income Avi to Common (ttm)

    23.98M

  • Diluted EPS (ttm)

    1.87

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    63.29M

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    17.53M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: